| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Accounting Officer
1 company
Lyon Joseph Douglas is a See Remarks at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $547K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | CORT Corcept Therapeutics Inc | See Remarks | Sale+OE | 500 | $26.01 | $13,003.50 | -6.4% | +26.9% | +257.1% | |
| Feb 16, 2024 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 1,000 | $26.00 | $26,000.00 | -12.9% | +21.3% | +220.2% | |
| Dec 4, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 5,000 | $26.00 | $130,000.00 | -29.9% | -8.0% | +127.2% | |
| Nov 2, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 5,000 | $28.10 | $140,520.11 | -29.9% | -16.6% | +88.3% | |
| Oct 6, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 2,582 | $27.24 | $70,333.68 | -30.6% | -4.0% | +72.1% | |
| Oct 2, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 2,418 | $27.25 | $65,888.81 | -29.2% | -8.1% | +77.8% | |
| Sep 1, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 5,000 | $32.73 | $163,650.00 | -49.3% | -23.1% | +6.6% | |
| Aug 21, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 4,588 | $31.19 | $143,099.72 | -47.2% | -17.4% | +9.2% | |
| Aug 7, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 412 | $31.22 | $12,862.64 | -8.0% | -14.3% | +13.2% | |
| Jun 6, 2023 | CORT Corcept Therapeutics Inc | Chief Accounting Officer | Sale+OE | 10,000 | $23.60 | $236,000.00 | -66.1% | +34.3% | +46.2% |